238 related articles for article (PubMed ID: 29610525)
1. CDH4 is a novel determinant of osteosarcoma tumorigenesis and metastasis.
Tang Q; Lu J; Zou C; Shao Y; Chen Y; Narala S; Fang H; Xu H; Wang J; Shen J; Khokha R
Oncogene; 2018 Jul; 37(27):3617-3630. PubMed ID: 29610525
[TBL] [Abstract][Full Text] [Related]
2. miR-216a inhibits osteosarcoma cell proliferation, invasion and metastasis by targeting CDK14.
Ji Q; Xu X; Li L; Goodman SB; Bi W; Xu M; Xu Y; Fan Z; Maloney WJ; Ye Q; Wang Y
Cell Death Dis; 2017 Oct; 8(10):e3103. PubMed ID: 29022909
[TBL] [Abstract][Full Text] [Related]
3. Mediator of RNA polymerase II transcription subunit 19 promotes osteosarcoma growth and metastasis and associates with prognosis.
Yu W; Zhang Z; Min D; Yang Q; Du X; Tang L; Lin F; Sun Y; Zhao H; Zheng S; He A; Li H; Yao Y; Shen Z
Eur J Cancer; 2014 Apr; 50(6):1125-36. PubMed ID: 24565852
[TBL] [Abstract][Full Text] [Related]
4. Knockdown of pyruvate kinase type M2 suppresses tumor survival and invasion in osteosarcoma cells both in vitro and in vivo.
Yuan Q; Yu H; Chen J; Song X; Sun L
Exp Cell Res; 2018 Jan; 362(1):209-216. PubMed ID: 29155364
[TBL] [Abstract][Full Text] [Related]
5. TRIM2 regulates the development and metastasis of tumorous cells of osteosarcoma.
Qin Y; Ye J; Zhao F; Hu S; Wang S
Int J Oncol; 2018 Oct; 53(4):1643-1656. PubMed ID: 30066883
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the metastatic phenotype of a panel of established osteosarcoma cells.
Ren L; Mendoza A; Zhu J; Briggs JW; Halsey C; Hong ES; Burkett SS; Morrow J; Lizardo MM; Osborne T; Li SQ; Luu HH; Meltzer P; Khanna C
Oncotarget; 2015 Oct; 6(30):29469-81. PubMed ID: 26320182
[TBL] [Abstract][Full Text] [Related]
7. TRIM66 overexpresssion contributes to osteosarcoma carcinogenesis and indicates poor survival outcome.
Chen Y; Guo Y; Yang H; Shi G; Xu G; Shi J; Yin N; Chen D
Oncotarget; 2015 Sep; 6(27):23708-19. PubMed ID: 26247633
[TBL] [Abstract][Full Text] [Related]
8. CDH4 suppresses the progression of salivary adenoid cystic carcinoma via E-cadherin co-expression.
Xie J; Feng Y; Lin T; Huang XY; Gan RH; Zhao Y; Su BH; Ding LC; She L; Chen J; Lin LS; Lin X; Zheng DL; Lu YG
Oncotarget; 2016 Dec; 7(50):82961-82971. PubMed ID: 27783992
[TBL] [Abstract][Full Text] [Related]
9. The predictive potential and oncogenic effects of HOXC8 expression on osteosarcoma.
Cheng L; Wei X; Zhao K; Wu F; Lu W; Tong S; Yu G
Tumour Biol; 2016 Nov; 37(11):14961-14967. PubMed ID: 27651160
[TBL] [Abstract][Full Text] [Related]
10. Knockdown of S100A4 decreases tumorigenesis and metastasis in osteosarcoma cells by repression of matrix metalloproteinase-9.
Zhang G; Li M; Jin J; Bai Y; Yang C
Asian Pac J Cancer Prev; 2011; 12(8):2075-80. PubMed ID: 22292654
[TBL] [Abstract][Full Text] [Related]
11. APLNR promotes the progression of osteosarcoma by stimulating cell proliferation and invasion.
Cui L; Zhang JY; Ren ZP; Zhao HJ; Li GS
Anticancer Drugs; 2019 Oct; 30(9):940-947. PubMed ID: 30920988
[TBL] [Abstract][Full Text] [Related]
12. [Downregulation of Herg1 suppresses osteosarcoma proliferation and invasion by targeting Hippo signaling pathway].
Chen ZD; Ye WB; Zeng WR; Song C; Song W; Zhang YM; Wu J
Zhonghua Zhong Liu Za Zhi; 2019 May; 41(5):338-345. PubMed ID: 31137166
[No Abstract] [Full Text] [Related]
13. Knockdown of DDX46 Inhibits the Invasion and Tumorigenesis in Osteosarcoma Cells.
Jiang F; Zhang D; Li G; Wang X
Oncol Res; 2017 Mar; 25(3):417-425. PubMed ID: 27697093
[TBL] [Abstract][Full Text] [Related]
14. Knockdown of PTHR1 in osteosarcoma cells decreases invasion and growth and increases tumor differentiation in vivo.
Ho PW; Goradia A; Russell MR; Chalk AM; Milley KM; Baker EK; Danks JA; Slavin JL; Walia M; Crimeen-Irwin B; Dickins RA; Martin TJ; Walkley CR
Oncogene; 2015 May; 34(22):2922-33. PubMed ID: 25043296
[TBL] [Abstract][Full Text] [Related]
15. The tumor suppressor miR-124 inhibits cell proliferation and invasion by targeting B7-H3 in osteosarcoma.
Wang L; Kang FB; Sun N; Wang J; Chen W; Li D; Shan BE
Tumour Biol; 2016 Nov; 37(11):14939-14947. PubMed ID: 27644254
[TBL] [Abstract][Full Text] [Related]
16. Long noncoding RNA BCAR4 promotes osteosarcoma progression through activating GLI2-dependent gene transcription.
Chen F; Mo J; Zhang L
Tumour Biol; 2016 Oct; 37(10):13403-13412. PubMed ID: 27460090
[TBL] [Abstract][Full Text] [Related]
17. Macrophage migration inhibitory factor promotes osteosarcoma growth and lung metastasis through activating the RAS/MAPK pathway.
Wang C; Zhou X; Li W; Li M; Tu T; Ba X; Wu Y; Huang Z; Fan G; Zhou G; Wu S; Zhao J; Zhang J; Chen J
Cancer Lett; 2017 Sep; 403():271-279. PubMed ID: 28642171
[TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA SNHG1 regulates NOB1 expression by sponging miR-326 and promotes tumorigenesis in osteosarcoma.
Wang J; Cao L; Wu J; Wang Q
Int J Oncol; 2018 Jan; 52(1):77-88. PubMed ID: 29115574
[TBL] [Abstract][Full Text] [Related]
19. Knockdown of galectin-1 suppresses the growth and invasion of osteosarcoma cells through inhibition of the MAPK/ERK pathway.
Miao JH; Wang SQ; Zhang MH; Yu FB; Zhang L; Yu ZX; Kuang Y
Oncol Rep; 2014 Oct; 32(4):1497-504. PubMed ID: 25069486
[TBL] [Abstract][Full Text] [Related]
20. MAT1 facilitates the lung metastasis of osteosarcoma through upregulation of AKT1 expression.
Wang J; Ni J; Song D; Ding M; Huang J; Li W; He G
Life Sci; 2019 Oct; 234():116771. PubMed ID: 31421084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
